 Connection
Co-Authors
This is a "connection" page, showing publications co-authored by Scott Sagel and Michael Zaretsky.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.538 |
|
|
|
-
Mustafa HJ, Blumenfeld YJ, Chmait RH, Taylor-Cousar JL, Hoppe JE, Martiniano SL, Metcalf A, Sagel SD, Zemanick ET, Shamshirsaz AA, Szentpetery SE, Trimble AT, Burgener EB, Luna-Paredes C, Sermet-Gaudelus I, Zaretsky MV. Prenatal CFTR modulator therapy for fetal cystic fibrosis: Emerging evidence, clinical considerations, and future directions. Pregnancy (Hoboken). 2026 Jul; 2(4):e70317.
Score: 0.245
-
Metcalf A, Hoppe JE, Martiniano SL, Zaretsky MV, Zemanick ET, Sagel SD. In Utero CFTR Modulator Therapy in Fetuses With Cystic Fibrosis. Neoreviews. 2026 03 01; 27(3):e157-e169.
Score: 0.238
-
Metcalf A, Martiniano SL, Sagel SD, Zaretsky MV, Zemanick ET, Hoppe JE. Outcomes of prenatal use of elexacaftor/tezacaftor/ivacaftor in carrier mothers to treat meconium ileus in fetuses with cystic fibrosis. J Cyst Fibros. 2025 05; 24(3):466-468.
Score: 0.055
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|